Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic
Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK™ Unit
Approved
Approval ID
d55cb701-9664-4931-8754-1a8cae68da06
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 1, 2022
Manufacturers
FDA
Fenwal, Inc.
DUNS: 794519020
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Anticoagulant Citrate Phosphate Dextrose (CPD) Solution
PRODUCT DETAILS
NDC Product Code0942-9201
Application NumberBN170401
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateNovember 1, 2022
Generic NameAnticoagulant Citrate Phosphate Dextrose (CPD) Solution
INGREDIENTS (5)
DEXTROSE MONOHYDRATEActive
Quantity: 893 mg in 35 mL
Code: LX22YL083G
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
ANHYDROUS CITRIC ACIDActive
Quantity: 105 mg in 35 mL
Code: XF417D3PSL
Classification: ACTIB
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEActive
Quantity: 78 mg in 35 mL
Code: 593YOG76RN
Classification: ACTIB
TRISODIUM CITRATE DIHYDRATEActive
Quantity: 921 mg in 35 mL
Code: B22547B95K
Classification: ACTIM